Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001976858 | SCV002267121 | likely benign | Saldino-Mainzer syndrome | 2023-08-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003170334 | SCV003896005 | uncertain significance | Inborn genetic diseases | 2023-02-06 | criteria provided, single submitter | clinical testing | The c.160C>T (p.P54S) alteration is located in exon 4 (coding exon 2) of the IFT140 gene. This alteration results from a C to T substitution at nucleotide position 160, causing the proline (P) at amino acid position 54 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005016999 | SCV005645326 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-04-18 | criteria provided, single submitter | clinical testing |